ALX ONCOLOGY HOLDINGS INC

For the period ended Dec 31, 2025. Filed Mar 9, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 9, 2026

ALXO$1.29+11.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

(in thousands, except share and per share data)

	December 31,	December 31,
	2025	2024
Assets
Current assets:
Cash and cash equivalents	$16,373	$17,567
Short-term investments	28,417	110,190
Prepaid expenses and other current assets	5,937	6,595
Total current assets	50,727	134,352
Property and equipment, net	1,200	2,905
Long-term investments	3,494	3,524
Other assets	3,625	6,994
Total assets	$59,046	$147,775
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable	$4,914	$4,497
Payable and accrued liabilities due to related party	—	149
Term loan, current	5,217	435
Accrued expenses and other current liabilities	14,422	13,419
Total current liabilities	24,553	18,500
Term loan, non-current	4,532	9,469
Other non-current liabilities	3,980	6,188
Total liabilities	33,065	34,157
Commitments and contingencies (Note 13)
Stockholders’ equity
Common stock, $0.001 par value; 1,000,000,000 shares authorized as of December 31, 2025 and December 31, 2024; 54,388,022 and 53,052,912 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively	54	53
Additional paid-in capital	748,716	734,412
Accumulated other comprehensive income	28	275
Accumulated deficit	(722,817)	(621,122)
Total stockholders’ equity	25,981	113,618
Total liabilities and stockholders’ equity	$59,046	$147,775

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.